Underpinned by higher capacity utilization, launch of some intermediates and increased supplies from the caffeine plant, Aarti's pharmaceuticals business in Q2 reported the highest revenue growth in at least six quarters. Thanks to increased benefits of operating leverage, EBIT margins soared to the highest level in at least ten quarters - 13.9% Vs 11.9% in Q2FY17 Vs 12..8% in Q1FY18. Despite miraculous jump in home...